The Indian Patent office has granted Process Patent No. IN384085 for 20 years to Kopran Research Laboratories Limited, Wholly owned Subsidiary of the Company for the Active Pharmaceutical Ingredient (API) product NITROXOLINE, for the invention titled "IMPROVED, COST EFFECTIVE PROCESS FOR PRODUCING NITROXOLINE."
Shares of Kopran Limited was last trading in BSE at Rs. 270.85 as compared to the previous close of Rs. 284.05. The total number of shares traded during the day was 22499 in over 821 trades.
The stock hit an intraday high of Rs. 284.45 and intraday low of 270.00. The net turnover during the day was Rs. 6211916.00.